During HCV DAA Therapy Plasma Mip1B, IP10, and miRNA Profile Are Distinctly Associated with Subsequent Diagnosis of Hepatocellular Carcinoma: A Pilot Study

During HCV DAA Therapy Plasma Mip1B, IP10, and miRNA Profile Are Distinctly Associated with Subsequent Diagnosis of Hepatocellular Carcinoma: A Pilot Study

<b>Background:</b> Hepatitis C virus (HCV) therapy lowers risk of hepatocellular carcinoma (HCC). Little is known about factors driving/preceding HCC in treated persons. MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) regulate host response and pathogenesis of disease. We investiga...

Full description

Bibliographic Details
Main Authors: Sofi Damjanovska, Hawwa Alao, Elizabeth Zebrowski, Corinne Kowal, Lenche Kostadinova, Perica Davitkov, Yngve Falck-Ytter, Carey L. Shive, Michael Cartwright, Brian Richardson, David Wald, Mark Cameron, Saba Valadkhan, Donald D. Anthony
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Biology
Subjects:
human
hepatitis C
direct acting antiviral
hepatocellular carcinoma
micro-RNA
long non-coding RNA
Online Access:https://www.mdpi.com/2079-7737/11/9/1262

Internet

https://www.mdpi.com/2079-7737/11/9/1262

Similar Items